|
Treatment Use
|
African Americans
|
Caucasian Americans
|
Crude
|
Sociodemographic Characteristics Adjusted†
|
Sociodemographic and Clinical Characteristics Adjusted‡
|
|---|
| |
(n = 508)
|
(n = 2075)
| | | |
|---|
| |
percentage
|
Odds ratios of African Americans relative to Caucasian Americans (95% confidence intervals)
|
|
CAM Only
|
16.5
|
24.2
|
0.76
|
0.77
|
0.68
|
| | | |
(0.57–1.01)
|
(0.56–1.06)
|
(0.48–0.96)
|
|
Conventional Medication Only
|
24.8
|
14.6
|
1.89
|
1.57
|
0.96
|
| | | |
(1.45–2.46)
|
(1.16–2.15)
|
(0.68–1.35)
|
|
Both
|
25.0
|
23.8
|
1.17
|
1.11
|
0.59
|
| | | |
(0.91–1.51)
|
(0.83–1.49)
|
(0.42–0.83)
|
|
Neither
|
33.7
|
37.5
|
Reference group of outcome variable
|
-
† Adjusted sociodemographics include age, gender, education, income, marital status and medication insurance coverage.
-
‡ Besides sociodemographic variables, full model also adjusted KOOS Pain and Quality of Life subscales, Kellgren-Lawrence Grade, history of knee injury or surgery, symptom-related multi-joint osteoarthritis, SF-12 mental health scale, SF-12 physical health scale and obesity status.
